Capricor Therapeutics (CAPR) Change in Account Payables (2010 - 2014)
Capricor Therapeutics (CAPR) recorded quarterly Change in Account Payables of -$61582.0 in Q3 2014, down 730.7% quarter-over-quarter from $9764.0 in Q2 2014, and down 49.5% on a YoY basis from -$121944.3 in Q3 2013.
Capricor Therapeutics (CAPR) Change in Account Payables (2010 - 2014) Analysis & Trends
Capricor Therapeutics' Change in Account Payables history runs 5 years deep, the most recent figure standing at -$61582.0 for Q3 2014.
- In Q3 2014, Change in Account Payables fell 49.5% year-over-year to -$61582.0; the TTM figure through Sep 2014 stood at $109224.0 (down 37.31% YoY), while the FY2013 annual figure was $97512.0, changed N/A from the prior year.
- Change in Account Payables was -$61582.0 for Q3 2014 at Capricor Therapeutics, down from $9764.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $437525.0 in Q3 2010 to a low of -$259173.0 in Q4 2010.
- Historically, Change in Account Payables has averaged $19968.6 across 5 years, with a median of $9764.0 in 2014.
- Biggest YoY gain for Change in Account Payables was 442.56% in 2012; the steepest drop was 175.56% in 2012.
- A 5-year view of Change in Account Payables shows it stood at -$259173.0 in 2010, then jumped by 74.34% to -$66496.0 in 2011, then jumped by 442.56% to $227787.0 in 2012, then plunged by 33.68% to $151079.0 in 2013, then plunged by 140.76% to -$61582.0 in 2014.
- The last three Change in Account Payables figures came in at -$61582.0 (Q3 2014), $9764.0 (Q2 2014), and $9963.0 (Q1 2014), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -9.42 Mn |
| 10 | Capricor Therapeutics | 1.53 Bn | 1.26 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | -61,582.00 |
| Sep 30, 2014 | -61,582.00 |
| Jun 30, 2014 | 9,764.00 |
| Jun 30, 2014 | 9,764.00 |
| Mar 31, 2014 | 9,963.00 |
| Mar 31, 2014 | 9,963.00 |
| Dec 31, 2013 | 151,079.00 |
| Dec 31, 2013 | 151,079.00 |
| Sep 30, 2013 | -41,192.00 |
| Sep 30, 2013 | -41,192.00 |
| Jun 30, 2013 | -22,338.00 |
| Jun 30, 2013 | -22,338.00 |
| Mar 31, 2013 | 9,963.00 |
| Mar 31, 2013 | 9,963.00 |
| Dec 31, 2012 | 227,787.00 |
| Dec 31, 2012 | 227,787.00 |
| Sep 30, 2012 | 88,331.00 |
| Sep 30, 2012 | 88,331.00 |
| Jun 30, 2012 | -205,435.00 |
| Jun 30, 2012 | -205,435.00 |